Results 131 to 140 of about 268,538 (298)

THE EFFECT OF ANGIOTENSIN I CONVERTING ENZYME INHIBITOR (SQ 20881) ON THE RELEASE OF PROSTAGLANDINS BY RABBIT KIDNEY, in vivo [PDF]

, 1977
Edward J. Johns, Robert Murdock, Bertha Singer   +2 more
openalex   +1 more source

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. [PDF]

, 2009
ObjectiveTo determine the frequency of use of pharmacotherapy with aspirin, beta blocker, statin, and angiotensin-converting enzyme (ACE) inhibitor in patients with stable coronary heart disease (CHD) among physicians at different levels of health care ...
Agrawal, Aachu, Bana, Ajeet, Deedwania, Prakash C, Gupta, Rajeev, Kasliwal, Atul, Roy, Sanjeeb, Sharma, Krishna K, Tongia, Ravindra K   +7 more
core   +1 more source

Regression of a venous malformation during angiotensin-converting enzyme inhibitor treatment for hypertension

Journal of Vascular Surgery Cases and Innovative Techniques, 2022
Recent studies have reported that components of the renin-angiotensin system (RAS) are expressed in venous malformations by embryonic stem cell-like subpopulations.
Sigurd Berger, MD, Therese Halvorsen Bjark, MD, Karsten Midtvedt, MD, PhD, Rune Andersen, MD   +3 more
doaj  

Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. [PDF]

, 1981
G. A. MacGregor, Nirmala D. Markandu, J Bayliss, J E Roulston, M. Squires, J.J. Morton   +5 more
openalex   +1 more source

The history of inhibitors of angiotensin converting enzyme

, 2001
This review paper by Sir John Vane, The Nobel Prize Laureate for the first time reveals the insides of discovery of inhibitors of angiotensin converting enzyme (ACE-1), presently known as important drugs for the treatment of hypertension, congestive heart failure and coronary artery disease.
openaire   +2 more sources

Drug points: Angioneurotic oedema associated with two angiotensin converting enzyme inhibitors [PDF]

, 1986
Donald R.J. Singer, Graham A. MacGregor
openalex   +1 more source

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Evidence From Randomized Controlled Trials (RCTs) of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Blockers — Questions Remain Unsolved

Journal of Pharmacological Sciences, 2010
Recent randomized controlled trials showed that blockade of the renin–angiotensin system (RAS) by angiotensin-converting enzyme (ACE) inhibitors and angiotensin II–receptor blockers (ARBs) reduced cardiovascular and renal events.
Shinichiro Ueda
doaj  

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019

Mayo Clinic proceedings, 2020
F. Sanchis-Gomar, C. Lavie, C. Pérez-Quilis, B. Henry, G. Lippi   +4 more
semanticscholar   +1 more source

Computational assessment of targeting angiotensin-converting enzyme for hypertension management: A structure-based virtual screening approach [PDF]

Background: Hypertension is a growing public health concern globally. The angiotensin-converting enzyme (ACE) is an enzyme that cleaves the carboxy-terminal His-Leu dipeptide from angiotensin I, yielding the potent vasopressor octapeptide, angiotensin II.
Alkathiri, Ahmad Salah
core   +2 more sources

THE EFFICACY OF COMBINED PHARMACOLOGICAL BLOCKING OF RAAS IN CHILDREN WITH CHRONIC RENAL DISEASE

Педиатрическая фармакология, 2010
14 children with various clinical forms of steroid-resistant nephrotic syndrome have been examined to assess the efficacy of pharmacological blocking of RAAS using inhibitors of angiotensin-converting enzyme and Angiotensin II receptor blockers.
E.S. Otroshchenko, L.V. Leonova, O.V. Komarova, A.G. Timofeeva, A.N. Tsygin   +4 more
doaj   +2 more sources